News & Events

February 2015

CDI__small_logo Share: facebook16x16px_green  twitter16x16px_green
masthead_enewsletter_CDINotebook

February 2015

Welcome to our monthly enewsletter, CDI Notebook, focused on keeping you abreast of the latest innovations using CDI’s iCell® and MyCell® products.

In this issue:
Trending
Publications
Press
Conference News

horizontal rule

Trending

Trending

Now Available! MyCell Disease and Diversity Products. Skip the time and expense of obtaining and reprogramming donor samples and get directly to performing research with these assay-ready, differentiated cells (cardiac, neural, hepatic, and more). MyCell Disease and Diversity Products are comprised of a growing list of specific phenotype/genotype iPS cells derived from donors or genetically engineered to represent a specific donor.

Details>>

horizontal rule

Publications

bogo

Building Richer Assays: Transfection of iPSC-derived Tissue Cells Is a Powerful Addition to the Biologist’s Tool Box. Learn about high-efficiency transfection of iPSC-derived hepatocytes, neurons, and cardiomyocytes and how biochemical and functional readouts can be combined in highly relevant human cell systems.

Anson BA. (2015) GEN.

Article>>

Assessment of Cardiomyocyte Contraction in Human-induced Pluripotent Stem Cell-derived Cardiomyocytes. Access this manuscript for new information on high-throughput assays for predicting drug-induced changes in human cardiomyocyte contractility and how these predictions correlate with traditional lower throughput gold standard methods using animal models.

Pointon A, Harmer AR, et al. (2014) Toxicol Sci.

Article>>

horizontal rule

Press

Cord Blood Registry and Cellular Dynamics Announce Collaboration. Discover how CBR and CDI are working together to provide iPS cells that could potentially treat disease.

Press Release>>

horizontal rule

Conference News

Society of Toxicology Annual Meeting & ToxExpo (Mar 22 – 26 | San Diego, CA | Booth 801). Join us at these SOT 2015 events:

  • Cardio-oncology Concerns Encourage Novel Approaches to Pharmaceutical Risk Assessment (Mar 23 | Symposium)
  • Toxicological Application of Studies Funded by California Stem Cell Research and Cures Act (Mar 23 | Informational Session)
  • Making Cardiotoxicity Prediction Simple and Relevant: Human iPSC-cardiomyocytes and Integrated Impedance- and Field Potential-based Assays Enable Highly Predictive Cardiotoxicity Assessments across Multiple Mechanisms (Mar 24 | Exhibitor-hosted Session)
  • Customer reception (Mar 23 | More details to come!)

AD/PD 2015 (Mar 18 – 22 | Nice, France | Booth 2A). Check out these posters during the International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders:

  • Characterization of an Isogenic Disease Model of Alzheimer’s Disease from Human iPS Cell-derived Neurons (Mar 18 | Exhibit Hall, Poster 5-0567)
  • Development and Characterization of Scalable Human Induced Pluripotent Stem Cell-derived Midbrain Dopaminergic Neurons for Drug Discovery and Disease Modeling (Mar 21 | Exhibit Hall, Poster 5-2244)
horizontal rule
© 2015 Cellular Dynamics International, Inc.
525 Science Drive, Madison, WI 53711
+1 (608) 310-5100 or toll-free (877) 310-6688
www.cellulardynamics.com
Follow us: facebook16x16px_green linkedin16x16px_green twitter16x16px_green youtube16x16px_green